Induction of Mitogen-activated Protein Kinase Phosphatase-1 by Arachidonic Acid in Vascular Smooth Muscle Cells
Bernhard Metzler,Yanhua Hu,Gertraud Sturm,Georg Wick,Qingbo Xu
DOI: https://doi.org/10.1074/jbc.273.50.33320
1998-01-01
Abstract:Arachidonic acid (AA) and its metabolites play important roles in a variety of biological processes, such as signal transduction, contraction, chemotaxis, and cell proliferation and differentiation. It was demonstrated recently that AA can activate mitogen-activated protein kinases (MAPKs), which are crucial for transducing signals initiating cell growth and apoptosis. Here we studied the effect of AA on the induction of MAPK phosphatase-1 (MKP-1) in vascular smooth muscle cells (VSMCs) and found that AA stimulated induction of MKP-1 mRNA and proteins in VSMCs in a time- and dose-dependent manner. Specific inhibitors of cyclooxygenase-, lipoxygenase-, and cytochrome P450-dependent metabolism did not affect AA-induced MKP-1 expression, indicating that eicosanoid biosynthesis was not involved in this process. The glutathione precursor N-acetylcysteine, an antioxidant, abolished AA-stimulated MKP-1 gene expression, whereas inhibition of protein kinase C by calphostin C had no influence on MKP-1 induction. VSMC pretreatment with genistein, a tyrosine kinase inhibitor, completely blocked AA-stimulated MKP-1 induction. MAPK kinase inhibitor PD 98059 did abolish AA-stimulated activation of extracellular signal-regulated kinases but not MKP-1 induction. Furthermore, agonists that increase AA release stimulated MKP-1 induction and activation of MAPKs, including extracellular signal-regulated kinases and c-Jun NH2-terminal protein kinases or stress-activated protein kinases. Taken together, our findings demonstrate that AA induced MKP-1 expression in VSMCs via activation of tyrosine kinases involving AA-induced free radical generation, suggesting an important role for MKP-1 in the regulation of AA-initiated signal transduction in VSMCs. Arachidonic acid (AA) and its metabolites play important roles in a variety of biological processes, such as signal transduction, contraction, chemotaxis, and cell proliferation and differentiation. It was demonstrated recently that AA can activate mitogen-activated protein kinases (MAPKs), which are crucial for transducing signals initiating cell growth and apoptosis. Here we studied the effect of AA on the induction of MAPK phosphatase-1 (MKP-1) in vascular smooth muscle cells (VSMCs) and found that AA stimulated induction of MKP-1 mRNA and proteins in VSMCs in a time- and dose-dependent manner. Specific inhibitors of cyclooxygenase-, lipoxygenase-, and cytochrome P450-dependent metabolism did not affect AA-induced MKP-1 expression, indicating that eicosanoid biosynthesis was not involved in this process. The glutathione precursor N-acetylcysteine, an antioxidant, abolished AA-stimulated MKP-1 gene expression, whereas inhibition of protein kinase C by calphostin C had no influence on MKP-1 induction. VSMC pretreatment with genistein, a tyrosine kinase inhibitor, completely blocked AA-stimulated MKP-1 induction. MAPK kinase inhibitor PD 98059 did abolish AA-stimulated activation of extracellular signal-regulated kinases but not MKP-1 induction. Furthermore, agonists that increase AA release stimulated MKP-1 induction and activation of MAPKs, including extracellular signal-regulated kinases and c-Jun NH2-terminal protein kinases or stress-activated protein kinases. Taken together, our findings demonstrate that AA induced MKP-1 expression in VSMCs via activation of tyrosine kinases involving AA-induced free radical generation, suggesting an important role for MKP-1 in the regulation of AA-initiated signal transduction in VSMCs. Mitogen-activated protein kinases (MAPKs), 1The abbreviations used are: MAPK(s), mitogen-activated protein kinase; AA, arachidonic acid; ERK, extracellular signal-regulated kinase; GST, glutathioneS-transferase; JNK, c-Jun NH2-terminal protein kinase; MKP, mitogen-activated protein kinase phosphatase; MOPS, 4-morpholinepropanesulfonic acid; PDGF, platelet-derived growth factor; PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; SAPK, stress-activated protein kinase; VSMC, vascular smooth muscle cell. 1The abbreviations used are: MAPK(s), mitogen-activated protein kinase; AA, arachidonic acid; ERK, extracellular signal-regulated kinase; GST, glutathioneS-transferase; JNK, c-Jun NH2-terminal protein kinase; MKP, mitogen-activated protein kinase phosphatase; MOPS, 4-morpholinepropanesulfonic acid; PDGF, platelet-derived growth factor; PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; SAPK, stress-activated protein kinase; VSMC, vascular smooth muscle cell. a ubiquitous group of serine/threonine kinases, are thought to play a crucial role in transmitting transmembrane signals required for cell growth, differentiation, and apoptosis (1Nishida E. Gotoh Y. Trends Biochem. Sci. 1993; 18: 128-131Abstract Full Text PDF PubMed Scopus (959) Google Scholar, 2Ruderman J.V. Curr. Opin. Cell Biol. 1993; 5: 207-213Crossref PubMed Scopus (118) Google Scholar, 3Seger R. Krebs E.G. FASEB J. 1995; 9: 726-735Crossref PubMed Scopus (3192) Google Scholar). At least three distinct subfamilies of MAPK exist: extracellular signal-regulated kinases (ERKs), c-Jun NH2-terminal protein kinases (JNKs) or stress-activated protein kinases (SAPKs), and p38 MAPKs (1Nishida E. Gotoh Y. Trends Biochem. Sci. 1993; 18: 128-131Abstract Full Text PDF PubMed Scopus (959) Google Scholar, 2Ruderman J.V. Curr. Opin. Cell Biol. 1993; 5: 207-213Crossref PubMed Scopus (118) Google Scholar, 3Seger R. Krebs E.G. FASEB J. 1995; 9: 726-735Crossref PubMed Scopus (3192) Google Scholar, 4Cano E. Mahadevan L.C. Trends Biochem. Sci. 1995; 20: 117-122Abstract Full Text PDF PubMed Scopus (997) Google Scholar, 5Dérijard B. Hibi M. Wu I.-H. Barrett T. Su B. Deng T. Karin M. Davis R.J. Cell. 1994; 76: 1025-1037Abstract Full Text PDF PubMed Scopus (2953) Google Scholar, 6Kyriakis J.M. Banerjee P. Nikolakaki E. Dai T. Rubie E.A. Ahmad M.F. Avruch J. Woodgett J.R. Nature. 1994; 369: 156-160Crossref PubMed Scopus (2411) Google Scholar, 7Davis R.J. J. Biol. Chem. 1993; 268: 14553-14556Abstract Full Text PDF PubMed Google Scholar). The ERKs, SAPKs, and p38 MAPKs are activated by the reversible dual threonine and tyrosine phosphorylation of a conserved TEY, TPY, or TGY motif, respectively (6Kyriakis J.M. Banerjee P. Nikolakaki E. Dai T. Rubie E.A. Ahmad M.F. Avruch J. Woodgett J.R. Nature. 1994; 369: 156-160Crossref PubMed Scopus (2411) Google Scholar, 7Davis R.J. J. Biol. Chem. 1993; 268: 14553-14556Abstract Full Text PDF PubMed Google Scholar, 8Cobb M.H. Goldsmith E.J. J. Biol. Chem. 1995; 270: 14843-14846Crossref PubMed Scopus (1659) Google Scholar, 9Sanchez I. Hughes R.T. Mayer B.J. Yee K. Woodgett J.R. Avruch J. Kyriakis J.M. Zon L.I. Nature. 1994; 372: 794-798Crossref PubMed Scopus (916) Google Scholar). Although distinct and selective MAPK activators have been cloned and characterized (1Nishida E. Gotoh Y. Trends Biochem. Sci. 1993; 18: 128-131Abstract Full Text PDF PubMed Scopus (959) Google Scholar, 2Ruderman J.V. Curr. Opin. Cell Biol. 1993; 5: 207-213Crossref PubMed Scopus (118) Google Scholar, 3Seger R. Krebs E.G. FASEB J. 1995; 9: 726-735Crossref PubMed Scopus (3192) Google Scholar, 4Cano E. Mahadevan L.C. Trends Biochem. Sci. 1995; 20: 117-122Abstract Full Text PDF PubMed Scopus (997) Google Scholar, 5Dérijard B. Hibi M. Wu I.-H. Barrett T. Su B. Deng T. Karin M. Davis R.J. Cell. 1994; 76: 1025-1037Abstract Full Text PDF PubMed Scopus (2953) Google Scholar, 6Kyriakis J.M. Banerjee P. Nikolakaki E. Dai T. Rubie E.A. Ahmad M.F. Avruch J. Woodgett J.R. Nature. 1994; 369: 156-160Crossref PubMed Scopus (2411) Google Scholar, 7Davis R.J. J. Biol. Chem. 1993; 268: 14553-14556Abstract Full Text PDF PubMed Google Scholar), less is known about negative regulation of these kinases. Several protein phosphatases with high specificity for MAPKs have been described, including the ubiquitously expressed rodent MAPK phosphatase-1 (MKP-1), its human homolog CL100, and the lymphocyte-specific PAC-1 protein (10Sun H. Charles C.H. Lau L.F. Tonks N.K. Cell. 1993; 75: 487-493Abstract Full Text PDF PubMed Scopus (1023) Google Scholar, 11Charles C.H. Sun H. Lau L.F. Tonks N.K. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 5292-5296Crossref PubMed Scopus (183) Google Scholar, 12Ward Y. Gupta S. Jensen P. Wartmann M. Davis R.J. Kelly K. Nature. 1994; 367: 651-654Crossref PubMed Scopus (295) Google Scholar, 13Alessi D.R. Smythe C. Keyse S.M. Oncogene. 1993; 8: 2015-2020PubMed Google Scholar, 14Liu Y. Gorospe M. Yang C. Holbrook N.J. J. Biol. Chem. 1995; 270: 8377-8380Crossref PubMed Scopus (285) Google Scholar). A number of studies have implicated MKP-1 in the regulation of mitogenesis (10Sun H. Charles C.H. Lau L.F. Tonks N.K. Cell. 1993; 75: 487-493Abstract Full Text PDF PubMed Scopus (1023) Google Scholar, 14Liu Y. Gorospe M. Yang C. Holbrook N.J. J. Biol. Chem. 1995; 270: 8377-8380Crossref PubMed Scopus (285) Google Scholar). MKP-1 has been shown to dephosphorylate phosphothreonine and phosphotyrosine residues of both ERKs and SAPKs, resulting in their inactivation, although it exhibits cell type specificity (10Sun H. Charles C.H. Lau L.F. Tonks N.K. Cell. 1993; 75: 487-493Abstract Full Text PDF PubMed Scopus (1023) Google Scholar, 11Charles C.H. Sun H. Lau L.F. Tonks N.K. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 5292-5296Crossref PubMed Scopus (183) Google Scholar, 12Ward Y. Gupta S. Jensen P. Wartmann M. Davis R.J. Kelly K. Nature. 1994; 367: 651-654Crossref PubMed Scopus (295) Google Scholar, 13Alessi D.R. Smythe C. Keyse S.M. Oncogene. 1993; 8: 2015-2020PubMed Google Scholar, 14Liu Y. Gorospe M. Yang C. Holbrook N.J. J. Biol. Chem. 1995; 270: 8377-8380Crossref PubMed Scopus (285) Google Scholar). Thus, the balance between MAPK activation and MKP-1 induction should be an important point in determining the fate of cells stimulated by environmental insults. Arachidonic acid (AA) and its metabolites are critical to a variety of biological processes, such as chemotaxis, inflammation, and signal transduction (15Hanahan D.J. Annu. Rev. Biochem. 1986; 55: 483-509Crossref PubMed Google Scholar, 16Axelrod J. Burch R.M. Jelsema C.L. Trends Neurosci. 1988; 11: 117-123Abstract Full Text PDF PubMed Scopus (428) Google Scholar). In addition to these functions, several investigators in recent years have reported that some peptide growth factors such as epidermal growth factor and fibroblast growth factors stimulate AA production in a number of cell types (17Peppelenbosch M.P. Tertoolen L.G. den Hertog J. deLaat S.W. Cell. 1992; 69: 295-303Abstract Full Text PDF PubMed Scopus (158) Google Scholar, 18Handler J.A. Danilowicz R.M. Eling T.E. J. Biol. Chem. 1990; 265: 3669-3673Abstract Full Text PDF PubMed Google Scholar, 19Sellmayer A. Uedelhoven W.M. Weber P.C. Bonventre J.V. J. Biol. Chem. 1991; 266: 3800-3807Abstract Full Text PDF PubMed Google Scholar, 20Fafeur V. Jiang Z.P. Bohlen P. J. Cell. Physiol. 1991; 149: 277-283Crossref PubMed Scopus (47) Google Scholar). In fact, it was also found that induction of mitogenesis by these growth factors required AA metabolism (18Handler J.A. Danilowicz R.M. Eling T.E. J. Biol. Chem. 1990; 265: 3669-3673Abstract Full Text PDF PubMed Google Scholar, 19Sellmayer A. Uedelhoven W.M. Weber P.C. Bonventre J.V. J. Biol. Chem. 1991; 266: 3800-3807Abstract Full Text PDF PubMed Google Scholar, 20Fafeur V. Jiang Z.P. Bohlen P. J. Cell. Physiol. 1991; 149: 277-283Crossref PubMed Scopus (47) Google Scholar). AA metabolites have been found to stimulate growth in many cell types, including vascular smooth muscle cells (VSMCs) when added exogenously (21Owen N.E. Am. J. Physiol. 1986; 250: C584-C588Crossref PubMed Google Scholar, 22Palmberg L. Claesson H.E. Thyberg J. J. Cell Sci. 1987; 88: 151-159PubMed Google Scholar, 23Setty B.N.Y. Graeber J.E. Stuart M.J. J. Biol. Chem. 1987; 262: 17613-17622Abstract Full Text PDF PubMed Google Scholar, 24Harris R.C. Homma T. Jacobson H.R. Capdevila J. J. Cell. Physiol. 1990; 144: 429-437Crossref PubMed Scopus (91) Google Scholar). Recently, it was demonstrated that AA activates both ERKs and JNKs/SAPKs in VSMCs or epithelial cells (25Rao G.N. Baas A.S. Glasgow W.C. Eling T.E. Runge M.S. Alexander R.W. J. Biol. Chem. 1994; 269: 32586-32591Abstract Full Text PDF PubMed Google Scholar, 26Hii C.S.T. Ferrante A. Edwards Y.S. Huang Z.H. Hartfield P.J. Rathjen D.A. Poulos A. Murray A.W. J. Biol. Chem. 1995; 270: 4201-4204Abstract Full Text Full Text PDF PubMed Scopus (106) Google Scholar, 27Cui X.L. Douglas J.G. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 3771-3776Crossref PubMed Scopus (163) Google Scholar), indicating an important role for AA and its metabolites in mitogenic signaling events. However, no data exist as to whether AA induces MKP-1 expression, which is important in regulating MAPK activity during cell proliferation. In the present study, we evaluated the potential effects of AA on MKP-1 induction in VSMCs using Western and Northern blot analyses and demonstrated that AA stimulation results in MKP-1 mRNA expression followed by increased protein induction. The mechanism appears to involve AA-stimulated superoxide generation, which activates tyrosine kinases and is independent of downstream eicosanoid biosynthesis and of protein kinase C (PKC) signal pathways. A rat MKP-1 cDNA was isolated from rat lung cDNA library by Liu et al. (14Liu Y. Gorospe M. Yang C. Holbrook N.J. J. Biol. Chem. 1995; 270: 8377-8380Crossref PubMed Scopus (285) Google Scholar). Plasmids expressing MKP-1 were propagated in Escherichia coli, and cDNA was obtained by cutting the plasmids with EcoRI. Polyclonal antibodies against rat MKP-1, mammalian ERK2, and JNK1/SAPK were obtained from Santa Cruz Biochemicals (Santa Cruz, CA). The monoclonal antibody against phosphorylated ERK1/2 was obtained from New England Biolabs, Inc. (Beverly, MA). Arachidonic acid, linoleic acid, stearic acid (tissue culture grade), calphostin C, phorbol 12-myristate 13-acetate (PMA), cinnamyl-3,4-dihydroxy-a-cyanocinnamate, and ketoconazole were obtained from BIOMOL Research Laboratories, Inc. (Plymouth Meeting, PA). Genistein, herbimycin A, andN-acetylcysteine were from Calbiochem-Novaniochem International (La Jolla, CA). H2O2 was purchased from E. Merck, Darmstadt, Germany. Indomethacin, angiotensin II, endothelin-1, bradykinin, and platelet-derived growth factor (PDGF)-AB were purchased from Sigma and PD 98059 from AlexisTM Biochemicals (Läufelfingen, Switzerland). VSMCs were isolated by enzymatic digestion of rat aortas according to the procedure of Ross and Kariya (28Ross R. Kariya B. Bohr D.F. Somlyo A.P. Sparks H.V. Handbook of Physiology: Circulation, Vascular Smooth Muscle. American Physiological Society, Bethesda, MD1980: 69-91Google Scholar) with a slight modification (29Xu Q. Li D. Holbrook N.J. Udelsman R. Circulation. 1995; 92: 1223-1229Crossref PubMed Scopus (101) Google Scholar) and cultured in medium RPMI 1640 (Life Technologies, Inc.) supplemented with 20% fetal calf serum, penicillin (100 units/ml), and streptomycin (100 μg/ml). Cells were incubated at 37 °C in a humidified atmosphere of 5% CO2 in air. The medium was changed every 3 days, and cells were passaged by treatment with a solution of 0.05% trypsin and 0.02% EDTA. Experiments were conducted on VSMCs that had just achieved confluence. VSMCs were serum starved for 4 days and incubated with AA in the presence or absence of inhibitors at 37 °C for the times indicated in figure legends. After two washes with cold (4 °C) phosphate-buffered saline, pH 7.4, cells were harvested on ice in buffer A containing 20 mm Hepes, pH 7.4, 2 mm EDTA, 1 mmβ-glycerophosphate, 1 mm dithiothreitol, 1 mmNa3VO4, 1% Triton, 10% glycerol, 1 μg/ml leupeptin, 1 μg/ml aprotinin, 400 μmphenylmethylsulfonyl fluoride. The suspension was incubated on ice for 20 min with vortexing every 5 min. Cellular debris were then pelleted by centrifugation for 30 min at 13,000 rpm (Eppendorf centrifuge, Osterode, Germany) at 4 °C, supernatants collected, and protein concentration measured by the Bio-Rad assay. Fifty μg of total VSMC proteins was separated by electrophoresis through a 10% SDS-polyacrylamide gel and transferred onto nitrocellulose membranes (BA85; Schleicher and Schuell, Dassel, Germany). After blocking with 5% nonfat dry milk (Sigma) for 1 h, the blots were probed with affinity-purified polyclonal antibodies against MKP-1 (1 μg/ml in phosphate-buffered saline containing 5% nonfat dry milk) or monoclonal antibodies against phosphorylated ERK1/2 for 2 h. The reaction was visualized using horseradish peroxidase-conjugated swine anti-rabbit or rabbit anti-mouse antibodies (Dako, Copenhagen, Denmark) at a 1:3,000 dilution. After two washes with phosphate-buffered saline, specific antibody-antigen complexes were detected using the ECL Western blot Detection Kit (Amersham Corp., Buckinghamshire, UK) as described previously (30Xu Q. Hu Y. Kleindienst R. Wick G. J. Clin. Invest. 1997; 100: 1089-1097Crossref PubMed Scopus (127) Google Scholar). Graphs of the blots were obtained in the linear range of detection and were quantified for the levels of specific induction or blocking by scanning laser densitometry (Power-Look II, UMAX Data System Inc., Hsinchu, Taiwan) of graphs. Total RNA (10 μg/lane) was isolated, denaturated with formaldehyde (Merck), electrophoresed in a 1% agarose gel, transferred onto a nylon membrane (Zeta Probe; Bio-Rad), and UV cross-linked in a UV Stratalinker (Stratagene Inc., La Jolla, CA). Hybridizations were performed using a fluorescein-labeled (Amersham Corp.) cDNA probe for MKP-1, as described previously (31Xu Q. Fawcett T.W. Gorospe M. Guyton K.Z. Liu Y. Holbrook N.J. Hypertension. 1997; 30: 106-111Crossref PubMed Scopus (32) Google Scholar). The membranes were then washed, detected with anti-fluorescein alkaline phosphatase conjugate (1:5,000) (Amersham Corp.), and exposed to ECL films (Amersham Corp.). Graphs of the blots were obtained in the linear range of detection. Accuracy of loading and transfer as well RNA integrity were confirmed by quantitative analysis of the 28 S and 18 S RNA. VSMCs were serum starved for 4 days, stimulated with AA, and harvested with buffer A. The cell suspension was incubated on ice for 15 min and centrifuged at 13,000 rpm for 30 min. The supernatant was harvested and protein concentration measured with Bio-Rad protein assay reagent (Bio-Rad). Protein A-Sepharose 4B suspension (Sigma) was added to the supernatant (100 μl/ml) and rotated for 2 h at 4 °C. After centrifugation at 13,000 rpm for 10 min, the supernatant was harvested. For kinase assays, 0.5 ml of the supernatant containing 0.5 mg of proteins was incubated with 10 μl of antibodies against mammalian ERK2 or JNK1/SAPK for 2 h at 4 °C with rotation. These antibodies have been shown to recognize specifically mammalian ERK2p42 and JNK1p54. Subsequently, 40 μl of protein A-Sepharose 4B suspension was added, and rotation continued for 1 h at 4 °C. Immunocomplexes were precipitated by centrifugation and washed twice with buffers A, B (500 mm LiCl, 100 mm Tris, 1 mmdithiothreitol, 0.1% Triton X-100, pH 7.6), and C (20 mmMOPS, 2 mm EGTA, 10 mm MgCl2, 1 mm dithiothreitol, 0.1% Triton X-100, pH 7.2), respectively. ERK2 activities in the immunocomplexes were measured as described previously (32Xu Q. Liu Y. Gorospe M. Udelsman R. Holbrook N.J. J. Clin. Invest. 1996; 97: 508-514Crossref PubMed Scopus (184) Google Scholar, 33Liu Y. Guyton K.Z. Gorospe M. Xu Q. Kokkonen G.C. Mock Y.D. Roth G.S. Holbrook N.J. J. Biol. Chem. 1996; 271: 3604-3607Abstract Full Text Full Text PDF PubMed Scopus (102) Google Scholar, 34Hu Y. Cheng L. Hochleitner B.W. Xu Q. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2808-2816Crossref PubMed Scopus (154) Google Scholar). Briefly, immunocomplexes were incubated with 35 μl of buffer C supplemented with 6 μg of myelin basic protein (Upstate Biotechnology, Inc., Lake Placid, NY), 5 μCi of [γ-32P]ATP, 50 mm MgCl2, and 30 μm ATP for 20 min at 37 °C with vortexing every 3 min. To stop the reaction, 15 μl of 4 × Laemmli buffer was added, and the mixture was boiled for 5 min. Proteins in the kinase reaction were resolved by SDS-polyacrylamide gel electrophoresis (15% gel) and subjected to autoradiography. The assay for JNK/SAPK activity was performed as described above using GST-c-Jun as substrate (the plasmid was provided by Dr. J. Woodgett) produced in E. coli and isolated using glutathione-Sepharose 4B RediPack Columns (Pharmacia Biotech Inc., Piscataway, NJ) per the manufacturer's protocol. Proteins in the kinase reaction were resolved by SDS-polyacrylamide gel electrophoresis (12% gel) and subjected to autoradiography (6Kyriakis J.M. Banerjee P. Nikolakaki E. Dai T. Rubie E.A. Ahmad M.F. Avruch J. Woodgett J.R. Nature. 1994; 369: 156-160Crossref PubMed Scopus (2411) Google Scholar, 35Hu Y. Metzler B. Xu Q. J. Biol. Chem. 1997; 272: 9113-9119Abstract Full Text Full Text PDF PubMed Scopus (60) Google Scholar). Analysis of variance was performed when more than two groups were compared. An unpaired Student'st test was used to assess differences between two groups. Ap value less than 0.05 was considered significant. Growth-arrested VSMCs were exposed to 20 μm AA for varying times, and protein extracts were prepared. Equal amounts of proteins from control and experimental samples were used to test MKP-1 induction using Western blot analysis. As shown in Fig.1 A, exposure of cells to AA resulted in a time-dependent induction of MKP-1 which was evident at 20 min, peaked at 1 h, and declined thereafter. Fig.1 B summarizes MKP-1 induction as determined by quantification of optical densities from autoradiograms of three experiments. Exposure of cells to AA produced 10–20-fold changes in MKP-1 after 1 or 2 h in protein extracts of VSMCs. AA-stimulated MKP-1 induction was also dose-dependent in that an increment in the proteins was observed at 2 μm and was maximal at 20 μm (Fig. 1 C). In addition, other fatty acids, including linoleic acid and stearic acid, did not significantly stimulate MKP-1 induction (data not shown). MKP-1 mRNA levels in AA-treated VSMCs were analyzed by Northern blots. As shown in Fig. 2, AA treatment resulted in significantly increased MKP-1 mRNA in VSMCs. Kinetic analysis of the response revealed that AA-induced MKP-1 mRNA expression occurred as early as 20 min (Fig. 2 A), with maximum levels (10-fold greater than untreated control) achieved between 20 min and 1 h after treatment and a return to basal levels thereafter. To establish further the relationship between AA treatment and MKP-1 expression, we performed a dose-response analysis of AA-induced MKP-1 mRNA accumulation. As shown in Fig.2 B, MKP-1 mRNA levels increased in a dose-dependent manner between 3 and 80 μm. The lower halves of Fig. 2 (Aand B) show the amount of 28 S and 18 S RNA from the corresponding blot. In most mammalian cells, AA is oxidized through the cyclooxygenase and/or cytochrome P450 pathways to yield eicosanoids that mediate biological effects. To evaluate the contributions of these metabolic pathways, VSMCs were treated with the cyclooxygenase inhibitor indomethacin, the lipoxygenase inhibitor cinnamyl-3,4-dihydroxy-a-cyanocinnamate, or the cytochrome P450 inhibitor ketoconazole for 30 min followed by stimulation with 20 μm AA. Indomethacin (20 μm) effectively inhibited 6-keto prostaglandin F1α production stimulated by exogenous AA in VSMCs (data not shown) and did not significantly stimulate MKP-1 induction (Fig.3, upper panel). Two other inhibitors did not stimulate MKP-1 production at doses known to abrogate eicosanoid biosynthesis in mammalian cells (36Civan M.M. Coca-Prados M. Peterson-Yantorno K. Invest. Opthalmol. Vis. Sci. 1994; 35: 2876-2886PubMed Google Scholar, 37Hata Y. Ota S. Nagata T. Uehara Y. Terano A. Sugimoto T. Prostaglandins. 1993; 45: 129-141Crossref PubMed Scopus (20) Google Scholar, 38Capdevila J. Gil L. Orellana M. Marnett L.J. Mason J.I. Yadagiri P. Falck J.R. Arch. Biochem. Biophys. 1988; 261: 257-263Crossref PubMed Scopus (168) Google Scholar) (Fig. 3). These inhibitors did not block the MKP-1 induction in AA-stimulated VSMCs but moderately enhanced this induction (Fig. 3). There is evidence that ketoconazole could effectively block ERK activation and calcium mobilization, but not JNK/SAPK activation, after AA stimulation (27Cui X.L. Douglas J.G. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 3771-3776Crossref PubMed Scopus (163) Google Scholar, 39Madhun Z.T. Goldthwait D.A. McKay D. Hopfer U. Douglas J.G. J. Clin. Invest. 1991; 88: 456-461Crossref PubMed Scopus (117) Google Scholar). Thus, our findings suggested that AA-stimulated MKP-1 induction in VSMCs did not require subsequent eicosanoid biosynthesis. Early studies demonstrated that AA activates PKC (40Kikkawa U. Ogita K. Shearman M.S. Ase K. Sekiguchi K. Naor Z. Ido M. Nishizuka Y. Saito N. Tanaka C. Ono Y. Fujii T. Igarashi K. Philos. Trans. R. Soc. Lond.-Biol. Sci. 1988; 320: 313-324Crossref PubMed Scopus (22) Google Scholar, 41Dell K.R. Severson D.L. Biochem. J. 1989; 258: 171-175Crossref PubMed Scopus (25) Google Scholar), and the PKC agonists PMA induces MKP-1 gene expression in several cell types. To determine whether PKC mediates AA-stimulated MKP-1 induction in VSMCs, PKC was either depleted by exposing VSMCs to 1 μm PMA for 24 h or inhibited by incubating the cells with calphostin C before AA stimulation. PMA pretreatment did not reduce MKP-1 or mRNA levels but enhanced the induction by AA (Fig.4). Similar findings were obtained with the PKC specific inhibitor, calphostin C, i.e. no significant inhibition of AA-induced expression (Fig. 4). Together, these results indicate that the AA-stimulated MKP-1 induction is independent of PKC. Because it has been demonstrated that AA stimulation results in superoxide generation, independent of PKC, in phagocytes (42Henderson L.M. Moule S.K. Chappell J.B. Eur. J. Biochem. 1993; 211: 157-162Crossref PubMed Scopus (77) Google Scholar, 43Sakata A. Ida E. Tominaga M. Onoue K. J. Immunol. 1987; 138: 4353-4359PubMed Google Scholar) and VSMCs (44Griendling K.K. Minieri C.A. Ollerenshaw J.D. Alexander R.W. Circ. Res. 1994; 74: 1141-1148Crossref PubMed Scopus (2377) Google Scholar), we assessed whether AA-induced MKP-1 expression was mediated by released free radicals via AA-activated NADPH oxidase. The antioxidant N-acetylcysteine, shown to be a superoxide anion scavenger, blocked H2O2-induced ERK activation in HeLa cells (45Guyton K.Z. Liu Y. Gorospe M. Xu Q. Holbrook N.J. J. Biol. Chem. 1996; 271: 4138-4142Abstract Full Text Full Text PDF PubMed Scopus (1138) Google Scholar). When N-acetylcysteine was added to the culture with adjusting pH of the medium, AA-stimulated MKP-1 production was inhibited in a dose-dependent manner (Fig.5). More than 50% of AA-stimulated protein induction was inhibited at a concentration of 40 mm(Fig. 5, A and B), whereas 20 mmabolished the MKP-1 mRNA induction by AA (Fig. 5, C andD). Moreover, VSMCs treated with H2O2 resulted in MKP-1 gene expression and MKP-1 induction in a dose-dependent manner (Fig.6), supporting the involvement of a redox mechanism of MKP-1 induction.Figure 6H2O2 stimulates MKP-1 induction. Panel A, Western blot analysis for the induction of MKP-1 by H2O2. After treatment with H2O2 in the indicated concentrations for 1 h, VSMCs were harvested for protein extracts and Western blot analysis as described under "Experimental Procedures." Panel B, Northern blot analysis for MKP-1 mRNA expression. Quiescent VSMCs were treated with H2O2 at 37 °C for 30 min and harvested for RNA isolation and Northern blot analysis as described in the legend to Fig. 2. The lower panel shows 28 S and 18 S RNA. AA, treated with arachidonic acid.View Large Image Figure ViewerDownload (PPT) Tyrosine kinases have been shown to be involved in several signal transduction pathways such as growth factor-ras-MAPKs and G-protein-dependent pathways (46Wan Y. Kurosaki T. Huang X.Y. Nature. 1996; 380: 541-544Crossref PubMed Scopus (258) Google Scholar, 47Tokiwa G. Dikic I. Lev S. Schlessinger J. Science. 1996; 273: 792-794Crossref PubMed Scopus (285) Google Scholar). Therefore, we pretreated VSMCs with genistein or herbimycin A to inhibit different types of tyrosine kinases. As shown in Fig.7, genistein treatment completely blocked AA-stimulated MKP-1 induction of both proteins and mRNA in VSMCs, whereas herbimycin A had a moderate influence in this induction (Fig.7). In addition, genistein alone stimulated a modicum of MKP-1 mRNA induction in VSMCs (Fig. 7 D), although the mechanism of this induction remains unknown. Our data support the involvement of genistein-sensitive tyrosine kinases in AA-induced MKP-1 expression. Both ERK and JNK/SAPK can be activated by AA (25Rao G.N. Baas A.S. Glasgow W.C. Eling T.E. Runge M.S. Alexander R.W. J. Biol. Chem. 1994; 269: 32586-32591Abstract Full Text PDF PubMed Google Scholar, 26Hii C.S.T. Ferrante A. Edwards Y.S. Huang Z.H. Hartfield P.J. Rathjen D.A. Poulos A. Murray A.W. J. Biol. Chem. 1995; 270: 4201-4204Abstract Full Text Full Text PDF PubMed Scopus (106) Google Scholar, 27Cui X.L. Douglas J.G. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 3771-3776Crossref PubMed Scopus (163) Google Scholar), and MKP-1 induction was demonstrated to be dependent on JNK/SAPK and/or ERK cascades (48Bokemeyer D. Sorokin A. Yan M. Ahn N.G. Templeton D.J. Dunn M.J. J. Biol. Chem. 1996; 271: 639-642Abstract Full Text Full Text PDF PubMed Scopus (153) Google Scholar, 49Brondello J.M. Brunet A. Pouyssegur J. McKenzie F.R. J. Biol. Chem. 1997; 272: 1368-1376Crossref PubMed Scopus (317) Google Scholar). To investigate whether these kinases are involved in AA-induced MKP-1 expression, ERK activities and MKP-1 induction were determined simultaneously in VSMCs pretreated with PD 98059, a specific MAPK kinase (MEK1/2) inhibitor. A marked activation o